Neurogenic inflammation in the airways

NeuroImmune Biology

Volumn 3, Issue C, 2003, Pages 437-449

  Barnes, Peter J ^a  

^a NATIONAL HEART AND LUNG INSTITUTE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 77957062232     PISSN: 15677443     EISSN: None     Source Type: Book Series    
DOI: 10.1016/S1567-7443(03)80057-1     Document Type: Article

References (68)

1. Barnes P.J. Modulation of neurotransmission in airways. Physiol Rev 72 (1992) 699-729
2. Maggi C.A., Giachetti A., Dey R.D., and Said S.I. Neuropeptides as regulators of airway function: vasoactive intestinal peptide and the tachykinins. Physiol Rev 75 (1995) 277-322
3. (in press). Barnes P.J. Neurogenic inflammation. Respirat Physiol (2001)
4. Sanico A.M., Atsuta S., Proud D., and Togias A. Dose-dependent effects of capsaicin nasal challenge: in vivo evidence of human airway neurogenic inflammation. J Allergy Clin Immunol 100 (1997) 632-641
5. Uddman R., Hakanson R., Luts A., and Sundler F. Distribution of neuropeptides in airways. In: Barnes P.J. (Ed). Autonomic Control of the Respiratory System (1997), Harwood Academic, London 21-37
6. Ho W.Z., Lai J.P., Zhu X.H., Uvaydova M., and Douglas S.D. Human monocytes and macrophages express substance P and neurokinin-1 receptor. J Immunol 159 (1997) 5654-5660
7. Frossard N., Rhoden K.J., and Barnes P.J. Influence of epithelium on guinea pig airway responses to tachykinins: role of endopeptidase and cyclooxygenase. J Pharmacol Exp Ther 248 (1989) 292-298
8. Harrison N.K., Dawes K.E., Kwon O.J., Barnes P.J., Laurent G.J., and Chung K.F. Effects of neuropeptides in human lung fibroblast proliferation and chemotaxis. Am J Physiol 12 (1995) L 278-L 283
9. Watson N., Maclagan J., and Barnes P.J. Endogenous tachykinins facilitate transmission through parasympathetic ganglia in guinea-pig trachea. Br J Pharmacol 109 (1993) 751-759
10. Daoui S., Cognon C., Naline E., Emonds-Alt X., and Advenier C. Involvement of tachykinin NK3 receptors in citric acid-induced cough and bronchial responses in guinea pigs. Am J Respir Crit Care Med 158 (1998) 42-48
11. Daoui S., Cui Y.Y., Lagente V., Emonds-Alt X., and Advenier C. A tachykinin NK3 receptor antagonist, SR 142801 (osanetant), prevents substance P-induced bronchial hyperreactivity in guinea-pigs. Pulm Pharmacol Ther 10 (1997) 261-270
12. Carstairs J.R., and Barnes P.J. Autoradiographic mapping of substance P receptors in lung. Eur J Pharmacol 127 (1986) 295-296
13. Mapp C.E., Miotto D., Braccioni F., Saetta M., Turato G., Maestrelli P., Krause J.E., Karpitskiy V., Boyd N., Geppetti P., and Fabbri L.M. The distribution of neurokinin-1 and neurokinin-2 receptors in human central airways. Am J Respir Crit Care Med 161 (2000) 207-215
14. Di Maria G.U., Bellofiore S., and Geppetti P. Regulation of airway neurogenic inflammation by neutral endopeptidase [In Process Citation]. Eur. Respir. J. 12 (1998) 1454-1462
15. Lotvall J.O., Elwood W., Tokuyama K., Barnes P.J., and Chung K.F. Differential effects of phosphoramidon on neurokinin A- and substance P-induced airflow obstruction and airway mkcrovascular leakage in guinea pig. Br J Pharmacol 104 (1991) 945-949
16. Cheung D., Bel E.H., den Hartigh J., Dijkman J.H., and Sterk P.J. An effect of an inhaled neutral endopeptidase inhibitor, thiorphan, on airway responses to neurokinin A in normal humans in vivo. Am Rev Respir Dis 145 (1992) 1275-1280
17. Mak J.C.W., and Barnes P.J. Autoradiographic localization of calcitonin gene-related peptide binding sites in human and guinea pig lung. Peptides 9 (1988) 957-964
18. Dunzendorfer S., Meierhofer C., and Wiedermann C.J. Signaling in neuropeptide-induced migration of human eosinophils. J Leukoc Biol 64 (1998) 828-834
19. McDonald D.M. Neurogenic inflammation in the respiratory tract: actions of sensory nerve mediators on blood vessels and epithelium of the airway mucosa. Am Rev Respir Dis 136 (1987) S65-S72
20. Solway J., and Leff A.R. Sensory neuropeptides and airway function. J Appl Physiol 71 (1991) 2077-2087
21. Ladenius A., Folkerts G., van der Linde H.J., and Nijkamp F.P. Potentiation by viral respiratory infection of ovalbumin-induced guinea-pig tracheal hyperresponsiveness: role for tachykinins. Br J Pharmacol 115 (1995) 1048-1052
22. Sestini P., Bienenstock J., Crowe S.E., Marshall J.S., Stead R.M., Kakuta Y., and Perdue M.H. Ion transport in rat tracheal ganglion in vitro. Role of capsaicin-sensitive nerves in allergic reactions. Am Rev Respir Dis 141 (1990) 393-3397
23. Tsukagoshi H., Sakamoto T., Xu W., Barnes P.J., and Chung K.F. Effect of interleukin-1b on airway hyperresponsiveness and inflammation in sensitized and non-sensitized Brown-Norway rats. J Allergy Clin Immunol 93 (1994) 464-469
24. 1-receptor antagonist. Br J Pharmacol 105 (1992) 261-262
25. 2) receptors. Am Rev Respir Dis 146 (1992) 1177-1181
26. Solway J., Kao B.M., Jordan J.E., Gitter B., Rodger I.W., Howbert J.J., Alger L.E., Necheles J., Leff A.R., and Garland A. Tachykinin receptor antagonists inhibit hypernea-induced bronchoconstriction in guinea pigs. J Clin Invest 92 (1993) 315-323
27. 1-receptor antagonist against substance P-, bradykin-, and allergen-induced airway microvascular leak and bronchoconstriction in the guinea pig. Eur J Pharmacol 231 (1993) 31-38
28. Barnes P.J., Belvisi M.G., and Rogers D.F. Modulation of neurogenic inflammation: novel approaches to inflammatory diseases. Trends Pharmacol Sci 11 (1990) 185-189
29. Spina D. Modulation of sensory nerve function in the airways. Pulm Pharmacol Ther 11 (1998) 319-330
30. Giuliani S., and Maggi C. Inhibition of tachykinin release from peripheral endings of sensory nerves by nociceptin, a novel opioid peptide. Br J Pharmacol 118 (1996) 1567-1570
31. Stretton C.D., Miura M., Belvisi M.G., and Barnes P.J. Calcium-activated potassium channels mediate prejunctional inhibition of peripheral sensory nerves. Proc Natl Acad Sci USA 89 (1992) 1325-1329
32. Kuo H.-P., Rohde J., Barnes P.J., and Rogers D.F. K+ channel activator inhibition of neurogenic goblet cell secretion in guinea pig trachea. Eur J Pharmacol 221 (1992) 385-388
33. Barnes P.J. Asthma as an axon reflex. Lancet i (1986) 242-245
34. A 1276. Bowden J., and Gibbins I.L. Relative density of substance P-immunoreactive nerve fibres in the tracheal epithelium of a range of species. FASEB J 6 (1992)
35. Levine J.D., Dardick S.J., Roizan M.F., Heims C., and Basbaum A.I. Contribution of sensory afferents and sympathetic efferents to joint injury in experimental arthritis. J Neurosci 6 (1986) 3423-3429
36. Holzer P. Local effector functions of capsaicin-sensitive sensory nerve endings: involvement of tachykinins, calcitonin gene related peptide, and otherneuropeptides. Neuroscience 24 (1988) 739-768
37. Lindsay R.M., and Harmar A.J. Nerve growth factor regulates expression of neuropeptide genes in sensory neurons. Nature 337 (1989) 362-364
38. Minami M., Kuraishi Y., Kawamura M., Yamaguchi T., Masu Y., and Nakanishi S. Enhancement of preprotachykinin A gene expression by adjuvant-induced inflammation in the rat spinal cord: possible inducement of substanceP-containing spinal neurons in nociceptor. Neurosci Lett 98 (1989) 105-110
39. Fischer A., McGregor G.P., Saria A., Philippin B., and Kummer W. Induction of tachykinin gene and peptide expression in guinea pig nodose primary afferent neurons by allergic airway inflammation. J Clin Invest 98 (1996) 2284-2291
40. Ollerenshaw S.L., Jarvis D., Sullivan C.E., and Woolcock A.J. Substance P immunoreactive nerves in airways from asthmatics and non-asthmatics. Eur Resp J 4 (1991) 673-682
41. Lilly C.M., Bai T.R., Shore S.A., Hall A.E., and Drazen J.M. Neuropeptide content of lungs from asthmatic and nonasthmatic patients. Am J Respir Crit Care Med 151 (1995) 548-553
42. Howarth P.H., Djukanovic R., Wilson J.W., Holgate S.T., Springall D.R., and Polak J.M. Mucosal nerves in endobronchial biopsies in asthma and non-asthma. Int Arch Allergy Appl Immunol 94 (1991) 330-333
43. Nieber K., Baumgarlen C.R., Rathsack R., Furkert J., Oehame P., and Kunkel G. Substance P and b-endorphin-like immunoreactivity in lavage fluids of subjects with and without asthma. J Allergy Clin Immunol 90 (1992) 646-652
44. Heaney L.G., Cross L.J., McGarvey L.P., Buchanan K.D., Ennis M., and Shaw C. Neurokinin A is the predominant tachykinin in human bronchoalveolar lavage fluid in normal and asthmatic subjects. Thorax 53 (1998) 357-362
45. Tomaki M., Ichinose M., Miura M., Hirayama Y., Yamauchi H., Nakajima N., and Shirato K. Elevated substance P content in induced sputum from patients with asthma, and patients with chronic bronchitis. Am J Respir Crit Care Med 151 (1995) 613-617
46. Fuller R.W., Dixon C.M.S., and Barnes P.J. The bronchoconstrictor response to inhaled capsaicin in humans. J Appl Physiol 85 (1985) 1080-1084
47. Midgren B., Hansson L., Karlsson J.A., Simonsson B.G., and Persson C. Capsaicin-induced cough in humans. Am Rev Respir Dis 146 (1992) 347-351
48. Fox A.J., Lalloo U.G., Belvisi M.G., Bernareggi M., Chung K.F., and Barnes P.J. Bradykinin-evoked sensitization of airway sensory nerves: a mechanism for ACE-inhibitor cough. Nature Med 2 (1996) 814-817
49. Ichinose M., Nakajima N., Takahashi T., Yamauchi H., Inoue H., and Takishima T. Protection against bradykinin-induced bronchoconstriction in asthmatic patients by a neurokinin receptor antagonist. Lancet 340 (1992) 1248-1251
50. Schmidt D., Jorres R.A., Rabe K.F., and Magnussen H. Reproducibility of airway response to inhaled bradykinin and effect of the neurokinin receptor antagonist FK-224 in asthmatic subjects. Eur J Clin Pharmacol 50 (1996) 269-273
51. Nichol G.M., O'Connor B.J., Le Compte J.M., Chung K.F., and Barnes P.J. Effect of neutral endopeptidase inhibitor on airway function and bronchial responsiveness in asthmatic subjects. Eur J Clin Pharmacol 42 (1992) 495-498
52. A682. Cheung D., Timmers M.C., Bel E.H., den Hartigh J., Dijuman J.H., and Sterk P.J. An isolated neutral endopeptidase inhibitor, thiorphan, enhances airway narrowing to neurokin A in asthmatic subjects in vivo. Am Rev Respir Dis 195 (1992)
53. Baraniuk J.N., Ohkubo O., Kwon O.J., Mak J.C.W., Davies R., Twort C., Kaliner M., Letarte M., and Barnes P.J. Localization of neutral endopeptidase (NEP) mRNA in human bronchi. Eur Respir J 8 (1995) 1458-1464
54. Adcock I.M., Peters M., Gelder C., Shirasaki H., Brown C.R., and Barnes P.J. Increased tachykinin receptor gene expression in asthmatic lung and its modulation by steroids. J Mol Endocrinol 11 (1993) 1-7
55. Bai T.R., and Bramley A.M. Effect of an inhibitor of nitric oxide synthase on neural relaxation of human bronchi. Am J Physiol. 264 (1993) L425-L430
56. 2 receptor expression and function in airway smooth muscle. Am J Respir Cell Mol Biol 21 (1999) 409-417
57. McAlpine L.G., and Thomson N.C. Lidocaine-induced bronchoconstriction in asthmatic patients. Relation to histamine airway responsiveness and effect of preservative. Chest 96 (1989) 1012-1015
58. Lammers J.-W., Minette P., McCusker M., Chung K.F., and Barnes P.J. Capsaicin-induced bronchodilatation in mild asthmatic subjects: possible role of nonadrenergic inhibitory system. J Appl Physiol 67 (1989) 856-861
59. Jackson D.M., Norris A.A., and Eady R.P. Nedocromil sodium and sensory nerves in the dog lung. Pulm Pharmacol 2 (1989) 179-184
60. Dixon C.M.S., Fuller R.W., and Barnes P.J. The effect of nedocromil sodium on sulphur dioxide induced bronchoconstriction. Thorax 42 (1987) 462-465
61. Dixon N., Jackson D.M., and Richards I.M. The effect of sodium cromoglycate on lung irritant receptors and left ventricular receptors in anasthetized dogs. Br J Pharmacol 67 (1979) 569-574
62. Verleden G.M., Belvisi M.G., Stretton C.D., and Barnes P.J. Nedocromil sodium modulates non-adrenergic non-cholinergic bronchoconstrictor nerves in guinea-pig airways in vitro. Am Rev Respir Dis 143 (1991) 114-118
63. Nichol G.M., Alton E., Nix A., Geddes D.M., Chung K.F., and Barnes P.J. Effect of inhaled furosemide on metabisulfite- and methacholine induced bronchoconstriction and nasal potential difference in asthmatic subjects. Am Rev Respir Dis 142 (1990) 576-580
64. Elwood W., Lotvall J.O., Barnes P.J., and Chung K.F. Loop diuretics inhibit cholinergic and non-cholinergic nerves in guinea pig airways. Am Rev Respir Dis 143 (1991) 1340-1344
65. Ventresca G.P., Nichol G.M., Barnes P.J., and Chung K.F. Inhaled furosemide inhibits cough induced by low chloride content solutions but not by capsaicin. Am Rev Respir Dis 142 (1990) 143-146
66. O'Connor B.J., Chen-Wordsell M., Barnes P.J., and Chung K.F. Effect of an inhaled opioid peptide on airway responses to sodium metabisulphite in asthma. Thorax 46 (1991) 294P
67. Ichinose M., Miura M., Yamauchi H., Kageyama N., Tomaki M., Oyake T., Ohuchi Y., Hida W., Miki H., Tamura G., and Shirato K. A neurokinin 1-receptor antagonist improves exercisc-induced airway narrowing in asthmatic patients. Am J Respir Crit Care Med 153 (1996) 936-941
68. 1 receptor antagonist (CP-99,994) on hypertonic saline-induced bronchoconstriction and cough in male asthmatic subjects. Am J Resp Crit Care Med 152 (1995) 879-884